Hollencrest Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.31K Hold
386
﹤0.01% 1010
2025
Q4
$2.77K Hold
386
﹤0.01% 976
2025
Q3
$4.12K Hold
386
﹤0.01% 916
2025
Q2
$3.74K Sell
386
-40
-9% -$413 ﹤0.01% 899
2025
Q1
$6.34K Hold
426
﹤0.01% 844
2024
Q4
$6.35K Hold
426
﹤0.01% 861
2024
Q3
$8.14K Buy
426
+1
+0.2% +$21 ﹤0.01% 789
2024
Q2
$8.81K Hold
425
﹤0.01% 760
2024
Q1
$8K Hold
425
﹤0.01% 742
2023
Q4
$6.13K Hold
425
﹤0.01% 784
2023
Q3
$7.38K Hold
425
﹤0.01% 765
2023
Q2
$8.84K Hold
425
﹤0.01% 772
2023
Q1
$9.99K Sell
425
-5
-1% -$134 ﹤0.01% 744
2022
Q4
$12K Buy
+430
New +$11K ﹤0.01% 699

Other funds holding OGN

Hollencrest Capital Management's OGN Position: Q1 2026 in Review

Hollencrest Capital Management held its Organon & Co (OGN) position steady in Q1 2026 at 386 shares worth $2.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

Hollencrest Capital Management first reported a position in OGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $12K in Q4 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Hollencrest Capital Management held 386 shares of Organon & Co worth $2.31K as of Q1 2026.
  • Hollencrest Capital Management left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q1 2026, its #1010 holding.
  • Hollencrest Capital Management first reported a position in Organon & Co in Q4 2022 and has held it in 14 quarters since.
  • Hollencrest Capital Management's Organon & Co position peaked at $12K in Q4 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Hollencrest Capital Management's 13F filing for Q1 2026, filed 7 May 2026.